Nirav Raval is a Cardiology physician affiliated with BayCare Health System. OpenAlex indexes 70 publications with 4,651 citations (h-index 18); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2415 N Orange Ave
Suite 600
Orlando, FL 328045505
Telephone
407-303-2172Provider last certified this registry record 15 May 2024.
Clinical trials
- A Study of Ularitide in the Treatment of Subjects With Acute Decompensated Heart Failure
Sponsor: Facet Biotech
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
22 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- CVRx, Inc.Program year202532 payments$17,183openpaymentsdata.cms.gov ↗
- Impulse Dynamics (USA) Inc.Program year202510 payments
- ABIOMEDProgram year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
51%Calcineurin inhibitor51%Tacrolimus100%Part D≥11 patientsMetabolism & gastrointestinal
27.5%SGLT2 inhibitor27.5%Jardiance100%Part D<11 patientsCardiovascular
21.6%Statin21.6%Rosuvastatin Calcium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- How to build a baroreceptor activation therapy (BAT) program: from development to implementation
Journal of Cardiac Failure - Intersections
2026 - Real-World Analysis of Health Care Utilization With Baroreflex Activation Therapy for Heart Failure
Journal of Cardiac Failure
2025 - Multimodal molecular testing provides prognostic value for heart transplant recipients
The Journal of Heart and Lung Transplantation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Crescentini, MD
BayCare Health System
Terrence Julien, MD
BayCare Health System
Devon Haydon, MD
BayCare Health System
Harold Colbassani, MD
BayCare Health System
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”